Mitsui Chemicals, Inc.
Notice regarding the completion of acquisition procedures for Ultron USA
The acquisition of Ultradent in the United States has been completed. Approvals and filings with competition authorities and investment regulators were completed earlier than expected, and the company announced a plan to transfer the global headquarters function for the oral care business from Japan to a U.S. holding company. The impact on consolidated results is under review.
Key Figures
- Acquisition completion date: 2026-08-14 (local time)
- Specific amount related to the acquisition: Unknown
- New group structure: Transfer of the oral care business's global headquarters function from Japan to a U.S. holding company
AI要約
Section Heading
This is a notice reporting the completion of the acquisition of Ultradent in the United States. As a prerequisite, disclosures regarding the signing of the acquisition agreement and the establishment of a new company have been made, and the acquisition procedures were completed today. It explains that approvals and filings with authorities regarding competition law and the Investment Control Act were completed earlier than anticipated. The plan is to transfer the global headquarters function for the oral care business from Japan to a U.S. holding company upon acquisition, aiming to maximize group-wide integration effects and to become a leading company. It is explicitly stated that the impact on consolidated results is under review.
Section 2
Future schedules and the formal disclosure of financial impacts are undecided. Additional information on the integration effects, implementation status, and financial impact after the acquisition will be disclosed as appropriate.
Mitsui Chemicals, Incorporated
Company overview · Stock price · Financial data · All IR
